
|Slideshows|August 11, 2017
FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review
Author(s)Natalie Timoshin
Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Grants Fast Track Designation to T-Cell Agent CK0803 for ALS
2
5-Year Data Support Safety of MRI-Guided AAV2-GDNF Gene Therapy in Advanced Parkinson Disease
3
AHA/ASA Issue New Guideline for Adult Stroke Rehabilitation and Recovery
4
Clinical Impacts of New FDA-Approved Oveporexton for Narcolepsy Type 1: Sara Sarkey, PhD
5













